The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro

@article{Rayan2005TheEO,
  title={The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro},
  author={Paran Rayan and Deborah J. Stenzel and Pauline Ann McDonnell},
  journal={Parasitology Research},
  year={2005},
  volume={97},
  pages={191-200}
}
Giardia duodenalis is a protozoal, intestinal parasite that is a common aetiological agent of infectious diarrhoea in humans worldwide. Chemotherapeutic intervention presently offers a limited range of drugs and these are usually only employed after clinical diagnosis. Moreover, these drugs are ineffective against the infectious cysts, can produce unpleasant side effects, and are expensive with limited availability in developing countries. Frequent reports of drug toxicity, treatment failure… 

Figures from this paper

A Complementary Herbal Product for Controlling Giardiasis
TLDR
Results show that A. annua extract is effective in alleviating infection-induced intestinal inflammation and pathological effects, which implies its potential therapeutic utility in controlling giardiasis.
Terminalia ferdinandiana extracts as inhibitors of Giardia duodenalis proliferation: a new treatment for giardiasis
TLDR
The low toxicity of the Terminalia ferdinandiana fruit extracts and their potent G. duodenalis growth inhibitory bioactivity indicate their potential as medicinal agents in the treatment and prevention of this disease.
An examination of the anti-bacterial, anti-fungal and anti-Giardial properties of macadamia nut
TLDR
The inhibitory bioactivity against a range of microbes as well as the lack of toxicity indicates the potential for macadamia nuts in the discovery and development of new natural food preservatives and pharmaceuticals.
Giardiasis: a pharmacotherapy review
TLDR
Some of the most important points of antigiardial pharmacotherapy available at present and the future prospects of development of new agents are examined.
Dietary Supplementation of Dodecanoic Acid in Maternal Mice Enhances Resistance to Giardia duodenalis Infection in Suckling Neonatal Pups
TLDR
The dietary supplementation of dodecanoic acid (and other compounds containing DA) to maternal mice was examined to determine whether such dietary changes could enhance resistance to G.duodenalis infection in suckling neonatal pups.
Evaluation of the therapeutic effect of extracts on experimental c
TLDR
This study showed that concurrent therapy to the conventional anti treatment with Nitazoxanide followed by Lauric acid showed the highest percentage of reduction in cryptosporidium parvum following treatment.
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?
TLDR
This study is a review of drugs used in in vitro and in vivo tests, and also drugs tested in clinical trials (nonrandomized and randomized).
An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts
TLDR
Traditional African therapeutic usage of K. africana in the treatment of several bacterial, fungal and protozoal illnesses and some cancers is validated, and its use in treating a variety of diseases is validated.
Pomegranate Peel Extract Is a Potential Alternative Therapeutic for Giardiasis
TLDR
The data show that the pomegranate peel extract is effective in controlling G. lamblia infections, which suggests that it could be a viable treatment option for giardiasis.
Lipid metabolism in Giardia: a post-genomic perspective
TLDR
A comprehensive pathway has been proposed to facilitate the understanding of lipid and fatty acid metabolism/syntheses in this waterborne pathogen and identify targets from the pathways that could be used to design novel therapies to control giardiasis and related diseases.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 106 REFERENCES
Lipid metabolism in mucous-dwelling amitochondriate protozoa.
Impact of medium-chain monoglycerides on intestinal colonisation by Vibrio cholerae or enterotoxigenic Escherichia coli.
TLDR
It is suggested that dietary MGs may prevent intestinal colonisation by bacterial enteropathogens if administered at the time of exposure, but have little effect on established intestinal infections.
Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture.
Human milk kills Giardia lamblia by generating toxic lipolytic products.
This study supports our previous hypotheses that normal human milk kills Giardia lamblia trophozoites in vitro and that this killing is due to the release of free fatty acids (FFAs) from milk
Uptake and cellular localization of exogenous lipids by Giardia lamblia, a primitive eukaryote.
TLDR
It is shown that G. lamblia is capable of taking up exogenous phosphatidylcholine (PC), phosph atidylinositol (PI), sphingomyelin (SM), cholesterol, ceramide (Cer), and fatty acids.
Zoonotic potential of giardiasis in domestic ruminants.
TLDR
It is postulated that domestic ruminants may be a reservoir for human infection and vice versa, thus classifying giardiasis as a zooanthroponotic disease.
Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids
TLDR
The data demonstrate that H. pylori is rapidly inactivated by medium-chain MGs and lauric acid and exhibits a relatively low frequency of spontaneous development of resistance to the bactericidal activity of MGs.
Drug resistance and Giardia.
Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori.
Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro.
TLDR
In vitro growth of the protozoan parasite Giardia lamblia was highly sensitive to certain anthelmintic benzimidazoles, and mebendazole was an attractive new antigiardial agent because of its lack of intestinal absorption.
...
1
2
3
4
5
...